Clinical Trials Logo
  1. Home
  2. Hemoglobinuria, Paroxysmal
  3. NCT00122330

Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients

Hemoglobinuria, Paroxysmal Clinical Trial

Official title:
Randomized, Double-Blind, and Placebo-Controlled Study Using Eculizumab in Transfusion Dependent PNH Patients

Clinical Trial Summary

The primary objective is to evaluate the safety and efficacy of eculizumab in transfusion dependent patients with hemolytic PNH.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Educational/Counseling/Training

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00122330
Study type Interventional
Source Alexion Pharmaceuticals
Contact
Status Completed
Phase Phase 3
Start date October 2004
Completion date January 2006
View Details
See also
  Status Clinical Trial Phase
Completed NCT00997386 - Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States Phase 2
Completed NCT00975975 - Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer Phase 2
Completed NCT00867932 - Eculizumab Pharmacokinetics/Pharmacodynamics Study in Pediatric/Adolescent Paroxysmal Nocturnal Hemoglobinuria (PNH) Phase 4
Completed NCT00721864 - The Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH) N/A
Completed NCT00152139 - Stem Cell Transplantation for Patients With Hematologic Malignancies Phase 3
Active, not recruiting NCT01642979 - Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria Phase 2
Active, not recruiting NCT01760096 - Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013) Phase 2
Completed NCT00618969 - Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors Phase 2
Completed NCT00098280 - Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria Phase 3
Completed NCT00122304 - Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab Phase 3
Recruiting NCT01224483 - Multicenter Retrospective Analysis About the Clinical Characteristics of Korean Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients N/A
Active, not recruiting NCT00315419 - Identifying Characteristics of Bone Marrow Failure Syndromes N/A
Approved for marketing NCT00438789 - The Paroxysmal Nocturnal Hemoglobinuria Early Access Treatment Protocol Phase 3